Bank of America
DTIL icon

Bank of America’s Precision BioSciences DTIL Stock Holding History

Bank of America’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151K Buy
27,416
+17,172
+168% +$79.2K ﹤0.01% 5443
2025
Q4 		$42.6K Buy
10,244
+10,038
+4,873% +$57K ﹤0.01% 5883
2025
Q3 		$1.14K Buy
206
+42
+26% +$201 ﹤0.01% 7477
2025
Q2 		$689 Buy
164
+32
+24% +$158 ﹤0.01% 7603
2025
Q1 		$630 Sell
132
-28,346
-100% -$144K ﹤0.01% 7488
2024
Q4 		$109K Buy
28,478
+20
+0.1% +$146 ﹤0.01% 6357
2024
Q3 		$255K Sell
28,458
-2
-0% -$19 ﹤0.01% 5890
2024
Q2 		$277K Buy
28,460
+47
+0.2% +$554 ﹤0.01% 5716
2024
Q1 		$385K Sell
28,413
-281
-1% -$3.44K ﹤0.01% 5500
2023
Q4 		$314K Buy
28,694
+6,248
+28% +$67.4K ﹤0.01% 5808
2023
Q3 		$230K Buy
22,446
+21,254
+1,783% +$327K ﹤0.01% 5829
2023
Q2 		$18.8K Sell
1,192
-101
-8% -$2.31K ﹤0.01% 6725
2023
Q1 		$29.2K Buy
1,293
+425
+49% +$14K ﹤0.01% 6649
2022
Q4 		$31K Sell
868
-39
-4% -$1.54K ﹤0.01% 6618
2022
Q3 		$36K Sell
907
-773
-46% -$36.7K ﹤0.01% 6806
2022
Q2 		$80K Buy
1,680
+13
+0.8% +$763 ﹤0.01% 6589
2022
Q1 		$155K Sell
1,667
-5,152
-76% -$700K ﹤0.01% 6620
2021
Q4 		$1.51M Buy
6,819
+4,998
+274% +$1.4M ﹤0.01% 4834
2021
Q3 		$631K Buy
1,821
+979
+116% +$332K ﹤0.01% 5457
2021
Q2 		$317K Sell
842
-1,998
-70% -$600K ﹤0.01% 5763
2021
Q1 		$882K Buy
2,840
+2,155
+315% +$754K ﹤0.01% 4939
2020
Q4 		$172K Sell
685
-1,223
-64% -$300K ﹤0.01% 5690
2020
Q3 		$353K Buy
1,908
+981
+106% +$195K ﹤0.01% 4956
2020
Q2 		$231K Buy
927
+41
+5% +$8.98K ﹤0.01% 5140
2020
Q1 		$160K Buy
886
+329
+59% +$86.1K ﹤0.01% 5232
2019
Q4 		$232K Buy
557
+441
+380% +$139K ﹤0.01% 5543
2019
Q3 		$29K Buy
116
+55
+90% +$17.9K ﹤0.01% 6495
2019
Q2 		$24K Buy
+61
New +$24.6K ﹤0.01% 6524

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Bank of America's DTIL Position: Q1 2026 in Review

Bank of America increased its Precision BioSciences (DTIL) stake by 168% in Q1 2026, buying an estimated $79.2K and bringing the position to 27,416 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #5443.

Bank of America first reported a position in DTIL in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.51M in Q4 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Bank of America held 27,416 shares of Precision BioSciences worth $151K as of Q1 2026.
  • Bank of America bought 17,172 Precision BioSciences shares in Q1 2026, an estimated $79.2K.
  • Precision BioSciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5443 holding.
  • Bank of America first reported a position in Precision BioSciences in Q2 2019 and has held it in 28 quarters since.
  • Bank of America's Precision BioSciences position peaked at $1.51M in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.